CareTrust REIT

CareTrust REIT acquired a portfolio of care facilities with 2,622 licensed beds for $400 million, leased under a long-term triple-net lease with inflation-based annual rent adjustments and renewal options. About $380 million was invested through a joint venture; the transaction was financed from cash and proceeds from equity forward transactions. The company expects a stabilized yield of roughly 8.6% and reports approximately $710 million of investments in the third quarter, bringing 2026 year-to-date volume to $1.9 billion across about two dozen transactions. » Mais em de.investing.com

CareTrust reported adjusted EPS of $0.38 in the second quarter, beating the consensus estimate, but missed revenue with $118.21 million. The company raised its full-year guidance for normalized FFO per share to $2.03–$2.06 and for normalized FAD per share to $2.01–$2.04. CareTrust invested roughly $900 million in the quarter (stabilized yield 8.9%) and described its pipeline of about $540 million as strong. The balance sheet remains conservative with net leverage of 1.0x relative to annualized run-rate EBITDA and liquidity of around $1.4 billion. Investors barely reacted, as the positive operating metrics offset the revenue miss. » Mais em de.investing.com

CareTrust REIT completed two transactions totaling $291 million, acquiring 18 healthcare properties in the US and the UK. These include two senior living communities in Utah for about $65 million and a portfolio of 16 nursing homes in England and Scotland for roughly $226 million. In the third quarter the company made additional investments, bringing Q3 investments to around $308 million with a stabilized yield of about 7.8%; 2026 investments to date total about $1.5 billion with a stabilized yield of about 8.7%. CareTrust also reports an investment pipeline with near-term opportunities of about $540 million. » Mais em de.investing.com

CareTrust shares rose to an all-time high of $43.10 and sit near their 52-week high; year-to-date performance is about 44.11%. In Q2 the company completed acquisitions totaling $864 million (Q1: $245 million) and announced a guaranteed placement of 12.5 million shares to raise roughly $509.4 million. Mizuho raised its price target to $45 and its FFO estimate for 2026 to $2.07, while Citizens confirmed “Market Outperform” with a $44 target. Management and analysts have revised forecasts for normalized distributable cash and FFO for 2026 upward. » Mais em de.investing.com

CareTrust shares fell to a 52-week low of about $38.45–$38.52, even though the company reported Q1 results that beat expectations for earnings and revenue and raised its 2026 guidance. InvestingPro estimates a fair value of $40.38 and views the stock as slightly undervalued, while CareTrust posted a one-year total return of 40% and a dividend yield of around 4%; the dividend has been increased for 10 consecutive years. CareTrust announced a guaranteed public offering of 12.5 million common shares (gross proceeds roughly $509.4 million). Analysts including Mizuho and Citizens raised and/or confirmed price targets ($45 and $44, respectively) and ratings, indicating positive growth expectations despite the share price declines. » Mais em de.investing.com